HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Yen, C.-C. Articles by Lin, K.-H. Search for Related Content PubMed PubMed Citation Articles by Yen, C.-C. Articles by Lin, K.-H.

Department of Biochemistry, Chang-Gung University, 259 Wen-hwa 1 Road, Taoyuan, Taiwan, Republic of China
¹ First Cardiovascular Division, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Republic of China

(Requests for offprints should be addressed to K-H Lin; Email: khlin{at}mail.cgu.edu.tw)

Thyroid hormone (triiodothyronine, T₃) regulates growth, development and differentiation. To examine the influence of T₃ on hepatoma cell growth, thyroid receptor (TR)1 or TRß1 over-expressing HepG2 cell lines were used. Growth of the HepG2-TR stable cell line was inhibited by over 50% following treatment with T₃. However, transforming growth factor (TGF)-ß neutralizing antibody, but not the control antibody can reverse the cell growth inhibition effect of T₃. Flow cytometric analysis indicated that the growth inhibition was apparent at the transition point between the G1 and S phases of the cell cycle. The expression of major cell cycle regulators was used to provide further evidence for the growth inhibition. Cyclin-dependent kinase 2 (cdk2) and cyclin E were down-regulated in HepG2-TR cells. Moreover, p21 protein or mRNA levels were up-regulated by around 5-fold or 7.3-fold respectively following T₃ treatment. Furthermore, phospho-retinoblastoma (ppRb) protein was down-regulated by T₃. The expression of TGF-ß was studied to delineate the repression mechanism. TGF-ß was stimulated by T₃ and its promoter activity was enhanced six- to eight-fold by T₃. Furthermore, both T₃ and TGF-ß repressed the expression of cdk2, cyclin E and ppRb. On the other hand, TGF-ß neutralizing but not control antibody blocked the repression of cdk2, cyclin E and ppRb by T₃. These results demonstrated that T₃ might play a key role in liver tumor cell proliferation.

This article has been cited by other articles:

				R.-N. Chen, Y.-H. Huang, Y.-C. Lin, C.-T. Yeh, Y. Liang, S.-L. Chen, and K.-H. Lin Thyroid Hormone Promotes Cell Invasion through Activation of Furin Expression in Human Hepatoma Cell Lines Endocrinology, August 1, 2008; 149(8): 3817 - 3831. [Abstract] [Full Text] [PDF]

				T. Otto and J. Fandrey Thyroid Hormone Induces Hypoxia-Inducible Factor 1{alpha} Gene Expression through Thyroid Hormone Receptor {beta}/Retinoid X Receptor {alpha}-Dependent Activation of Hepatic Leukemia Factor Endocrinology, May 1, 2008; 149(5): 2241 - 2250. [Abstract] [Full Text] [PDF]

				R.-N. Chen, Y.-H. Huang, C.-T. Yeh, C.-H. Liao, and K.-H. Lin Thyroid Hormone Receptors Suppress Pituitary Tumor Transforming Gene 1 Activity in Hepatoma Cancer Res., March 15, 2008; 68(6): 1697 - 1706. [Abstract] [Full Text] [PDF]

				G. Fava, Y. Ueno, S. Glaser, H. Francis, S. DeMorrow, L. Marucci, M. Marzioni, A. Benedetti, J. Venter, B. Vaculin, et al. Thyroid hormone inhibits biliary growth in bile duct-ligated rats by PLC/IP3/Ca2+-dependent downregulation of SRC/ERK1/2 Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1467 - C1475. [Abstract] [Full Text] [PDF]